These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38356866)
1. Lnc-CCNH-8 promotes immune escape by up-regulating PD-L1 in hepatocellular carcinoma. Zhao B; Zheng X; Wang Y; Cheng N; Zhong Y; Zhou Y; Huang J; Wang F; Qi X; Zhuang Q; Wang Y; Liu X Mol Ther Nucleic Acids; 2024 Mar; 35(1):102125. PubMed ID: 38356866 [TBL] [Abstract][Full Text] [Related]
2. N Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901 [TBL] [Abstract][Full Text] [Related]
3. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation. Ke MY; Xu T; Fang Y; Ye YP; Li ZJ; Ren FG; Lu SY; Zhang XF; Wu RQ; Lv Y; Dong J Cancer Lett; 2021 Aug; 513():14-25. PubMed ID: 33992711 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA COX7C-5 promotes hepatocellular carcinoma progression via miR-581/ZEB2 axis. Lin Y; Wang F; Zhong Y; Cheng NM; Xiong J; Zheng X; Zhou Y; Gao S; Li F; Wang Y; Yang X; Zhao B Cell Signal; 2023 Jan; 101():110501. PubMed ID: 36273755 [TBL] [Abstract][Full Text] [Related]
5. Lnc-PLA2G4A-4 facilitates the progression of hepatocellular carcinoma by inducing versican expression via sponging miR-23b-3p. Xiong J; Lai Y; Cheng N; Liu J; Wang F; Zheng X; Wang Y; Zhuang Q; Lin Y; Liu J; Yang Y; Zhao B; Yang X Heliyon; 2023 Aug; 9(8):e18698. PubMed ID: 37554815 [TBL] [Abstract][Full Text] [Related]
6. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303 [TBL] [Abstract][Full Text] [Related]
7. Deciphering the shield: Lnc-CCNH-8's pivotal role in crafting PD-L1-mediated immune camouflage in hepatocellular carcinoma. Song SY; Li Y; Wang Y Mol Ther Nucleic Acids; 2024 Mar; 35(1):102151. PubMed ID: 38444703 [No Abstract] [Full Text] [Related]
8. Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression. Peng L; Pan B; Zhang X; Wang Z; Qiu J; Wang X; Tang N Cell Biol Toxicol; 2022 Dec; 38(6):1159-1173. PubMed ID: 35438468 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of M2 type macrophage-derived extracellular vesicles regulating PD-L1 expression via the MISP/IQGAP1 axis in hepatocellular carcinoma immunotherapy resistance. Wang X; Ye X; Chen Y; Lin J Int Immunopharmacol; 2023 Nov; 124(Pt A):110848. PubMed ID: 37633233 [TBL] [Abstract][Full Text] [Related]
10. Pivotal role of long non-coding ribonucleic acid-X-inactive specific transcript in regulating immune checkpoint programmed death ligand 1 through a shared pathway between miR-194-5p and miR-155-5p in hepatocellular carcinoma. Atwa SM; Handoussa H; Hosny KM; Odenthal M; El Tayebi HM World J Hepatol; 2020 Dec; 12(12):1211-1227. PubMed ID: 33442449 [TBL] [Abstract][Full Text] [Related]
11. lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response. Zhang X; Pan B; Qiu J; Ke X; Shen S; Wang X; Tang N Int J Exp Pathol; 2022 Jun; 103(3):102-111. PubMed ID: 35429078 [TBL] [Abstract][Full Text] [Related]
12. KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D. Wang Y; Cao K J Immunol Res; 2021; 2021():9965099. PubMed ID: 34307695 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-associated circPRDM4 promotes immune escape via HIF-1α regulation of PD-L1 in hepatocellular carcinoma. Chen ZQ; Zuo XL; Cai J; Zhang Y; Han GY; Zhang L; Ding WZ; Wu JD; Wang XH Exp Hematol Oncol; 2023 Feb; 12(1):17. PubMed ID: 36747292 [TBL] [Abstract][Full Text] [Related]
14. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Hu Z; Chen G; Zhao Y; Gao H; Li L; Yin Y; Jiang J; Wang L; Mang Y; Gao Y; Zhang S; Ran J; Li L Mol Cancer; 2023 Mar; 22(1):55. PubMed ID: 36932387 [TBL] [Abstract][Full Text] [Related]
15. Dual targeting of PD-L1 and PD-L2 by PCED1B-AS1 via sponging hsa-miR-194-5p induces immunosuppression in hepatocellular carcinoma. Fan F; Chen K; Lu X; Li A; Liu C; Wu B Hepatol Int; 2021 Apr; 15(2):444-458. PubMed ID: 33219943 [TBL] [Abstract][Full Text] [Related]
16. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation. Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380 [TBL] [Abstract][Full Text] [Related]
17. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma. Xing R; Gao J; Cui Q; Wang Q Front Immunol; 2021; 12():783236. PubMed ID: 34899747 [TBL] [Abstract][Full Text] [Related]
18. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905 [TBL] [Abstract][Full Text] [Related]
19. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885 [TBL] [Abstract][Full Text] [Related]
20. Huaier improves the efficacy of anti-PD-L1 Ab in the treatment of hepatocellular carcinoma by regulating tumor immune microenvironment. Li H; You J; Wei Y; Zheng L; Yang J; Xu J; Li Y; Li Z; Yang X; Yi C Phytomedicine; 2024 Jan; 123():155189. PubMed ID: 37984124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]